Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
AKZOY Stock Summary
Top 10 Correlated ETFs
AKZOY
In the News
AkzoNobel N.V. (AKZOF) Q4 2023 Earnings Call Transcript
AkzoNobel N.V. (AKZOF) Q4 2023 Earnings Call Transcript
New Strong Sell Stocks for November 16th
AKZOY, FMNB and MAXN have been added to the Zacks Rank #5 (Strong Sell) List on November 16, 2023.
New Strong Sell Stocks for November 14th
AKZOY, GTX and HROW have been added to the Zacks Rank #5 (Strong Sell) List on November 14, 2023.
Akzo Nobel N.V. (AKZOF) Q3 2023 Earnings Call Transcript
Akzo Nobel N.V. (OTCQX:AKZOF) Q3 2023 Earnings Conference Call October 25, 2023 3:00 AM ET Company Participants Kenny Chae - Head of IR Gregoire Poux-Guillaume - CEO Maarten de Vries - CFO Conference Call Participants Charlie Webb - Morgan Stanley Laurent Favre - BNP Gunther Zechmann - Bernstein Chetan Udeshi - JPMorgan Peter Clark - Societe Generale Matthew Yates - Bank of America Geoffrey Haire - UBS Jaideep Pandya - On Field Research Aron Ceccarelli - Berenberg Operator Hello, and welcome to today's AkzoNobel Q3 2023 Results Call.
3 Stocks to Avoid With Oil Prices Near 10-Month Highs
The price of West Texas Intermediate oil has retreated slightly from its recent high of $91.48, which was the most elevated price for the commodity since November 2022. As of the morning of Sept.
Akzo Nobel: Underdiscussed And With Great Potential
Akzo Nobel is positioned for solid long-term growth after a financial decline due to a cyclical downturn in the paint and coating industry. The company is the third-largest player globally in its respective industry, with a strong portfolio of brands and products and exposure to faster-growing industry verticals. Akzo Nobel has promising growth prospects, especially in the Chinese market, and is well-positioned to capitalize on the steady growth trajectory of the industry.
AKZOY vs. AIQUY: Which Stock Is the Better Value Option?
Investors interested in Chemical - Diversified stocks are likely familiar with Akzo Nobel NV (AKZOY) and Air Liquide (AIQUY). But which of these two stocks offers value investors a better bang for their buck right now?
AkzoNobel (AKZOY) Up 17% YTD: What's Driving the Stock?
AkzoNobel (AKZOY) benefits from its cost actions, growth through strategic acquisitions and efforts to improve its operations and deliver innovative solutions to customers.
Why You Should Add AkzoNobel (AKZOY) Stock to Your Portfolio
AkzoNobel (AKZOY) gains on its cost actions, strategic acquisitions and efforts to improve operations and deliver innovative solutions to customers.
AKZOY or AIQUY: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Chemical - Diversified sector might want to consider either Akzo Nobel NV (AKZOY) or Air Liquide (AIQUY). But which of these two companies is the best option for those looking for undervalued stocks?
AKZOY Financial details
AKZOY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 14.51 | 14.85 | 17.28 | 20.69 | 62.54 | |
Net income per share | 0.84 | 1.1 | 1.49 | 0.67 | 2.59 | |
Operating cash flow per share | 0.05 | 2.12 | 1.09 | 0.5 | 7.09 | |
Free cash flow per share | -0.28 | 1.67 | 0.57 | -0.06 | 5.42 | |
Cash per share | 2.19 | 3.23 | 2.18 | 3.41 | 10.42 | |
Book value per share | 9.93 | 10 | 9.78 | 8.27 | 25.34 | |
Tangible book value per share | 4.6 | 4.17 | 3.51 | 0.91 | -5.66 | |
Share holders equity per share | 9.93 | 10 | 9.78 | 8.27 | 25.34 | |
Interest debt per share | 3.64 | 5.2 | 6.53 | 11.41 | 32.6 | |
Market cap | 19.34B | 16.94B | 18B | 10.96B | 4.28B | |
Enterprise value | 20.29B | 18.23B | 20.4B | 15.39B | 8.33B | |
P/E ratio | 35.88 | 26.89 | 21.72 | 31.14 | 9.69 | |
Price to sales ratio | 2.09 | 1.99 | 1.88 | 1.01 | 0.4 | |
POCF ratio | 586.08 | 13.89 | 29.76 | 41.68 | 3.54 | |
PFCF ratio | -106.85 | 17.61 | 56.79 | -378.03 | 4.63 | |
P/B Ratio | 3.05 | 2.95 | 3.32 | 2.53 | 0.99 | |
PTB ratio | 3.05 | 2.95 | 3.32 | 2.53 | 0.99 | |
EV to sales | 2.19 | 2.14 | 2.13 | 1.42 | 0.78 | |
Enterprise value over EBITDA | 16.11 | 13.24 | 13.33 | 14.3 | 5.83 | |
EV to operating cash flow | 614.81 | 14.94 | 33.72 | 58.51 | 6.88 | |
EV to free cash flow | -112.09 | 18.94 | 64.36 | -530.62 | 9.02 | |
Earnings yield | 0.03 | 0.04 | 0.05 | 0.03 | 0.1 | |
Free cash flow yield | -0.01 | 0.06 | 0.02 | 0 | 0.22 | |
Debt to equity | 0.35 | 0.5 | 0.65 | 1.36 | 1.24 | |
Debt to assets | 0.17 | 0.22 | 0.26 | 0.4 | 0.36 | |
Net debt to EBITDA | 0.75 | 0.93 | 1.57 | 4.11 | 2.83 | |
Current ratio | 1.58 | 1.64 | 1.1 | 1.09 | 1.06 | |
Interest coverage | 7.38 | 9.93 | 15.11 | 6.68 | 5.6 | |
Income quality | 0.06 | 1.8 | 0.7 | 0.68 | 2.71 | |
Dividend Yield | 0.07 | 0.02 | 0.02 | 0.03 | 0.08 | |
Payout ratio | 2.68 | 0.61 | 0.47 | 1.08 | 0.78 | |
Sales general and administrative to revenue | 0.04 | 0.03 | 0.03 | 0.03 | 0 | |
Research and developement to revenue | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
Intangibles to total assets | 0.28 | 0.27 | 0.27 | 0.28 | 0.27 | |
Capex to operating cash flow | -6.48 | -0.21 | -0.48 | -1.11 | -0.24 | |
Capex to revenue | -0.02 | -0.03 | -0.03 | -0.03 | -0.03 | |
Capex to depreciation | -0.59 | -0.71 | -0.82 | -0.79 | -0.81 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | -0.04 | |
Graham number | 13.73 | 15.71 | 18.13 | 11.17 | 38.44 | |
ROIC | 0.07 | 0.08 | 0.09 | 0.04 | 0.07 | |
Return on tangible assets | 0.06 | 0.07 | 0.08 | 0.03 | 0.04 | |
Graham Net | -4.45 | -5.74 | -7.94 | -10.62 | -34.13 | |
Working capital | 1.74B | 1.97B | 479M | 498M | 338M | |
Tangible asset value | 2.94B | 2.4B | 1.95B | 476M | 465M | |
Net current asset value | -1.67B | -2.16B | -2.89B | -3.95B | -4.31B | |
Invested capital | 0.35 | 0.5 | 0.65 | 1.36 | 1.24 | |
Average receivables | 2.14B | 2.06B | 2.19B | 2.48B | 2.57B | |
Average payables | 1.86B | 1.96B | 2.2B | 2.29B | 2.26B | |
Average inventory | 1.14B | 1.15B | 1.4B | 1.75B | 1.75B | |
Days sales outstanding | 83.93 | 85.15 | 91.3 | 86.05 | 88.2 | |
Days payables outstanding | 129.46 | 156.31 | 151.3 | 116.31 | 127.13 | |
Days of inventory on hand | 78.31 | 89.15 | 105.07 | 97.17 | 90.67 | |
Receivables turnover | 4.35 | 4.29 | 4 | 4.24 | 4.14 | |
Payables turnover | 2.82 | 2.34 | 2.41 | 3.14 | 2.87 | |
Inventory turnover | 4.66 | 4.09 | 3.47 | 3.76 | 4.03 | |
ROE | 0.08 | 0.11 | 0.15 | 0.08 | 0.1 | |
Capex per share | -0.33 | -0.45 | -0.52 | -0.56 | -1.68 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.99 | 5.19 | 5.36 | 5.36 | 14.82 | |
Net income per share | 0.03 | 0.18 | 0.23 | 0.37 | 0.24 | |
Operating cash flow per share | 0.56 | -0.1 | 0.6 | 0.58 | 3.86 | |
Free cash flow per share | 0.37 | -0.22 | 0.49 | 0.47 | 3.31 | |
Cash per share | 3.42 | 2.99 | 3.39 | 3.72 | 10.42 | |
Book value per share | 8.3 | 8.64 | 8.19 | 8.58 | 25.33 | |
Tangible book value per share | 0.91 | 1.17 | 0.74 | 0.9 | -5.66 | |
Share holders equity per share | 8.3 | 8.64 | 8.19 | 8.58 | 25.33 | |
Interest debt per share | 11.32 | 11.44 | 11.98 | 11.87 | 31.81 | |
Market cap | 10.92B | 12.22B | 12.86B | 11.76B | 4.28B | |
Enterprise value | 15.34B | 16.81B | 17.45B | 16.1B | 8.33B | |
P/E ratio | 160.54 | 32.5 | 27.24 | 15.56 | 26.11 | |
Price to sales ratio | 4.19 | 4.6 | 4.69 | 4.29 | 1.69 | |
POCF ratio | 37.51 | -244.41 | 42.16 | 39.61 | 6.51 | |
PFCF ratio | 55.98 | -109.11 | 51.64 | 48.41 | 7.58 | |
P/B Ratio | 2.52 | 2.77 | 3.07 | 2.68 | 0.99 | |
PTB ratio | 2.52 | 2.77 | 3.07 | 2.68 | 0.99 | |
EV to sales | 5.89 | 6.33 | 6.36 | 5.87 | 3.29 | |
Enterprise value over EBITDA | 85.71 | 56.97 | 47.54 | 35.7 | 29.13 | |
EV to operating cash flow | 52.72 | -336.13 | 57.2 | 54.22 | 12.66 | |
EV to free cash flow | 78.68 | -150.06 | 70.06 | 66.27 | 14.75 | |
Earnings yield | 0 | 0.01 | 0.01 | 0.02 | 0.01 | |
Free cash flow yield | 0.02 | -0.01 | 0.02 | 0.02 | 0.13 | |
Debt to equity | 1.36 | 1.31 | 1.45 | 1.37 | 1.24 | |
Debt to assets | 0.4 | 0.4 | 0.41 | 0.4 | 0.36 | |
Net debt to EBITDA | 24.72 | 15.55 | 12.5 | 9.62 | 14.16 | |
Current ratio | 1.09 | 1.1 | 1.13 | 1.16 | 1.06 | |
Interest coverage | 3.12 | 3.19 | 6.2 | 5.21 | 3.33 | |
Income quality | 17.12 | -0.47 | 2.29 | 1.5 | 14.95 | |
Dividend Yield | 0.01 | 0 | 0.02 | 0 | 0.02 | |
Payout ratio | 5.29 | 0.04 | 2.27 | 0.08 | 1.85 | |
Sales general and administrative to revenue | -0.79 | 0.3 | 0.3 | 0.3 | 0 | |
Research and developement to revenue | 0.1 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.28 | 0.28 | 0.27 | 0.28 | 0.27 | |
Capex to operating cash flow | -0.33 | 1.24 | -0.18 | -0.18 | -0.14 | |
Capex to revenue | -0.04 | -0.02 | -0.02 | -0.02 | -0.04 | |
Capex to depreciation | -1.01 | -0.71 | -0.64 | -0.61 | -1 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | -0.07 | |
Graham number | 2.47 | 5.98 | 6.52 | 8.44 | 11.7 | |
ROIC | 0 | 0.01 | 0.02 | 0.02 | 0.01 | |
Return on tangible assets | 0 | 0.01 | 0.01 | 0.02 | 0 | |
Graham Net | -10.67 | -10.73 | -10.99 | -10.58 | -34.13 | |
Working capital | 498M | 573M | 750M | 894M | 338M | |
Tangible asset value | 476M | 597M | 379M | 463M | 465M | |
Net current asset value | -3.95B | -3.88B | -4.01B | -3.81B | -4.31B | |
Invested capital | 1.36 | 1.31 | 1.45 | 1.37 | 1.24 | |
Average receivables | 2.79B | 2.67B | 2.86B | 2.97B | 2.79B | |
Average payables | 2.69B | 2.45B | 2.77B | 2.9B | 2.95B | |
Average inventory | 1.95B | 1.84B | 1.8B | 1.74B | 1.68B | |
Days sales outstanding | 88.31 | 94.13 | 96.7 | 98.34 | 91.74 | |
Days payables outstanding | 118.53 | 145.18 | 155.94 | 164.43 | 175.4 | |
Days of inventory on hand | 99.03 | 98.81 | 96.72 | 95.45 | 98.61 | |
Receivables turnover | 1.02 | 0.96 | 0.93 | 0.92 | 0.98 | |
Payables turnover | 0.76 | 0.62 | 0.58 | 0.55 | 0.51 | |
Inventory turnover | 0.91 | 0.91 | 0.93 | 0.94 | 0.91 | |
ROE | 0 | 0.02 | 0.03 | 0.04 | 0.01 | |
Capex per share | -0.18 | -0.12 | -0.11 | -0.11 | -0.55 |
AKZOY Frequently Asked Questions
What is Akzo Nobel N.V. stock symbol ?
Akzo Nobel N.V. is a NL stock and trading under the symbol AKZOY
What is Akzo Nobel N.V. stock quote today ?
Akzo Nobel N.V. stock price is $25.33 today.
Is Akzo Nobel N.V. stock public?
Yes, Akzo Nobel N.V. is a publicly traded company.